SCHEMBL3953138

SCHEMBL3953138

CC1=NN(c2cc(Cl)c(S(=O)(=O)[O-])cc2Cl)C(=O)C1/N=N/c1ccc(S(=O)(=O)O)cc1.CC1=NN(c2cc(Cl)c(S(=O)(=O)[O-])cc2Cl)C(=O)C1/N=N/c1ccc(S(=O)(=O)O)cc1.[Na+].[Na+]

nearest known ligand 0.48

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 14/20 0.48
▸ MEN1 O00255 13/20 0.48
▸ MAPT P10636 7/20 0.48
▸ GAA P10253 2/20 0.48
▸ CYP1A2 P05177 2/20 0.48
▸ NPC1 O15118 9/20 0.44
▸ RAB9A P51151 7/20 0.44
▸ CASP3 P42574 2/20 0.44
▸ SENP7 Q9BQF6 2/20 0.44
▸ SENP6 Q9GZR1 2/20 0.44
▸ SENP8 Q96LD8 1/20 0.44
▸ ALDH1A1 P00352 6/20 0.43
▸ SMN1; SMN2 Q16637 3/20 0.43
▸ LMNA P02545 3/20 0.43
▸ TDP1 Q9NUW8 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ KDM4E B2RXH2 2/20 0.42
▸ POLB P06746 2/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ ATM Q13315 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3953150 1.00 KMT2A (0.48) KMT2AMEN1MAPTGAACYP1A2
SCHEMBL226987 0.93 MEN1 (0.51) KMT2AMEN1MAPTGAACYP1A2
SCHEMBL3953142 0.93 MEN1 (0.51) KMT2AMEN1MAPTGAACYP1A2
SCHEMBL23064842 0.93 KMT2A (0.51) KMT2AMEN1MAPTGAACYP1A2
SCHEMBL9112323 0.93 KMT2A (0.51) KMT2AMEN1MAPTGAACYP1A2
SCHEMBL3953146 0.92 KMT2A (0.50) KMT2AMEN1MAPTGAACYP1A2
SCHEMBL1615065 0.86 KMT2A (0.53) KMT2AMEN1MAPTGAACYP1A2
SCHEMBL29544137 0.85 MAPT (0.57) KMT2AMEN1MAPTGAACYP1A2
SCHEMBL18038402 0.85 KMT2A (0.53) KMT2AMEN1MAPTGAACYP1A2
SCHEMBL1615061 0.85 KMT2A (0.53) KMT2AMEN1MAPTGAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1335964-B1 USE OF HIGH SOLIDS SOLUTION OF A CATIONIC COPOLYMER IN PERSONAL CARE FORMULATIONS AND PERSONAL CARE FORMULATIONS OBTAINED THEREFROM CIBA HOLDING INC (CH) 2009-07-15 — — EP disclosed
Send feedback